CN43 Maintaining intravenous anti-cancer systemic therapy during COVID: Pharmacy and nursing factors
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2021-09, Vol.32, p.S1272-S1272 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | S1272 |
|---|---|
| container_issue | |
| container_start_page | S1272 |
| container_title | Annals of oncology |
| container_volume | 32 |
| creator | O'Dwyer, R.T. Connolly, W. Hamilton, S. Kelly, S. Lynch, A. Martin, F. Dempsey, K. Rondthaler, A. Ryan, B. Byrne, A. Corrigan, R. Lawless, R. Conlon, L. Hickey, P. Manning, A. Egan, K. Breathnach, O.S. O'Shea, C. Christie, A. Treanor, L. |
| description | |
| doi_str_mv | 10.1016/j.annonc.2021.08.672 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8454362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S092375342102901X</els_id><sourcerecordid>S092375342102901X</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2012-d40286def3240d0f8802edc43cbb208d1084a9870288a26041f5a23930c434613</originalsourceid><addsrcrecordid>eNp9kF9LwzAUxYMoOKffwId-gdabP-1SHwSp_wbqfFBfQ5akW8aajqQd9NubMlF88eGSC_ecE84PoUsMGQZcXG0y6VzrVEaA4Ax4VszIEZrgvChTDgwfowmUhKaznLJTdBbCBgCKkpQTpKtXRpMXaV0Xx7pVEjcv98a1fUik62yqpFPGJ2EInWmsSrq18XI3JLr3o75afM7vrpO3tfSNVEP06MT1Poy3Wqqu9eEcndRyG8zF9ztFHw_379VT-rx4nFe3z6kigEmqGRBeaFNTwkBDzTkQoxWjarkkwDUGzmTJZ1HFJSlisTqXhJYUooYVmE7RzSF31y-b6DRjla3YedtIP4hWWvH34uxarNq94CxntCAxgB0ClG9D8Kb-8WIQI2qxEQfUYkQtgIuI-vdfE8vtrfEiKGsiNW29UZ3Qrf0_4AtqB4rH</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>CN43 Maintaining intravenous anti-cancer systemic therapy during COVID: Pharmacy and nursing factors</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>O'Dwyer, R.T. ; Connolly, W. ; Hamilton, S. ; Kelly, S. ; Lynch, A. ; Martin, F. ; Dempsey, K. ; Rondthaler, A. ; Ryan, B. ; Byrne, A. ; Corrigan, R. ; Lawless, R. ; Conlon, L. ; Hickey, P. ; Manning, A. ; Egan, K. ; Breathnach, O.S. ; O'Shea, C. ; Christie, A. ; Treanor, L.</creator><creatorcontrib>O'Dwyer, R.T. ; Connolly, W. ; Hamilton, S. ; Kelly, S. ; Lynch, A. ; Martin, F. ; Dempsey, K. ; Rondthaler, A. ; Ryan, B. ; Byrne, A. ; Corrigan, R. ; Lawless, R. ; Conlon, L. ; Hickey, P. ; Manning, A. ; Egan, K. ; Breathnach, O.S. ; O'Shea, C. ; Christie, A. ; Treanor, L.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1016/j.annonc.2021.08.672</identifier><language>eng</language><publisher>Elsevier Ltd</publisher><ispartof>Annals of oncology, 2021-09, Vol.32, p.S1272-S1272</ispartof><rights>2021 European Society for Medical Oncology</rights><rights>Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. 2021 European Society for Medical Oncology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids></links><search><creatorcontrib>O'Dwyer, R.T.</creatorcontrib><creatorcontrib>Connolly, W.</creatorcontrib><creatorcontrib>Hamilton, S.</creatorcontrib><creatorcontrib>Kelly, S.</creatorcontrib><creatorcontrib>Lynch, A.</creatorcontrib><creatorcontrib>Martin, F.</creatorcontrib><creatorcontrib>Dempsey, K.</creatorcontrib><creatorcontrib>Rondthaler, A.</creatorcontrib><creatorcontrib>Ryan, B.</creatorcontrib><creatorcontrib>Byrne, A.</creatorcontrib><creatorcontrib>Corrigan, R.</creatorcontrib><creatorcontrib>Lawless, R.</creatorcontrib><creatorcontrib>Conlon, L.</creatorcontrib><creatorcontrib>Hickey, P.</creatorcontrib><creatorcontrib>Manning, A.</creatorcontrib><creatorcontrib>Egan, K.</creatorcontrib><creatorcontrib>Breathnach, O.S.</creatorcontrib><creatorcontrib>O'Shea, C.</creatorcontrib><creatorcontrib>Christie, A.</creatorcontrib><creatorcontrib>Treanor, L.</creatorcontrib><title>CN43 Maintaining intravenous anti-cancer systemic therapy during COVID: Pharmacy and nursing factors</title><title>Annals of oncology</title><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kF9LwzAUxYMoOKffwId-gdabP-1SHwSp_wbqfFBfQ5akW8aajqQd9NubMlF88eGSC_ecE84PoUsMGQZcXG0y6VzrVEaA4Ax4VszIEZrgvChTDgwfowmUhKaznLJTdBbCBgCKkpQTpKtXRpMXaV0Xx7pVEjcv98a1fUik62yqpFPGJ2EInWmsSrq18XI3JLr3o75afM7vrpO3tfSNVEP06MT1Poy3Wqqu9eEcndRyG8zF9ztFHw_379VT-rx4nFe3z6kigEmqGRBeaFNTwkBDzTkQoxWjarkkwDUGzmTJZ1HFJSlisTqXhJYUooYVmE7RzSF31y-b6DRjla3YedtIP4hWWvH34uxarNq94CxntCAxgB0ClG9D8Kb-8WIQI2qxEQfUYkQtgIuI-vdfE8vtrfEiKGsiNW29UZ3Qrf0_4AtqB4rH</recordid><startdate>202109</startdate><enddate>202109</enddate><creator>O'Dwyer, R.T.</creator><creator>Connolly, W.</creator><creator>Hamilton, S.</creator><creator>Kelly, S.</creator><creator>Lynch, A.</creator><creator>Martin, F.</creator><creator>Dempsey, K.</creator><creator>Rondthaler, A.</creator><creator>Ryan, B.</creator><creator>Byrne, A.</creator><creator>Corrigan, R.</creator><creator>Lawless, R.</creator><creator>Conlon, L.</creator><creator>Hickey, P.</creator><creator>Manning, A.</creator><creator>Egan, K.</creator><creator>Breathnach, O.S.</creator><creator>O'Shea, C.</creator><creator>Christie, A.</creator><creator>Treanor, L.</creator><general>Elsevier Ltd</general><general>European Society for Medical Oncology. Published by Elsevier Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>202109</creationdate><title>CN43 Maintaining intravenous anti-cancer systemic therapy during COVID: Pharmacy and nursing factors</title><author>O'Dwyer, R.T. ; Connolly, W. ; Hamilton, S. ; Kelly, S. ; Lynch, A. ; Martin, F. ; Dempsey, K. ; Rondthaler, A. ; Ryan, B. ; Byrne, A. ; Corrigan, R. ; Lawless, R. ; Conlon, L. ; Hickey, P. ; Manning, A. ; Egan, K. ; Breathnach, O.S. ; O'Shea, C. ; Christie, A. ; Treanor, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2012-d40286def3240d0f8802edc43cbb208d1084a9870288a26041f5a23930c434613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>O'Dwyer, R.T.</creatorcontrib><creatorcontrib>Connolly, W.</creatorcontrib><creatorcontrib>Hamilton, S.</creatorcontrib><creatorcontrib>Kelly, S.</creatorcontrib><creatorcontrib>Lynch, A.</creatorcontrib><creatorcontrib>Martin, F.</creatorcontrib><creatorcontrib>Dempsey, K.</creatorcontrib><creatorcontrib>Rondthaler, A.</creatorcontrib><creatorcontrib>Ryan, B.</creatorcontrib><creatorcontrib>Byrne, A.</creatorcontrib><creatorcontrib>Corrigan, R.</creatorcontrib><creatorcontrib>Lawless, R.</creatorcontrib><creatorcontrib>Conlon, L.</creatorcontrib><creatorcontrib>Hickey, P.</creatorcontrib><creatorcontrib>Manning, A.</creatorcontrib><creatorcontrib>Egan, K.</creatorcontrib><creatorcontrib>Breathnach, O.S.</creatorcontrib><creatorcontrib>O'Shea, C.</creatorcontrib><creatorcontrib>Christie, A.</creatorcontrib><creatorcontrib>Treanor, L.</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>O'Dwyer, R.T.</au><au>Connolly, W.</au><au>Hamilton, S.</au><au>Kelly, S.</au><au>Lynch, A.</au><au>Martin, F.</au><au>Dempsey, K.</au><au>Rondthaler, A.</au><au>Ryan, B.</au><au>Byrne, A.</au><au>Corrigan, R.</au><au>Lawless, R.</au><au>Conlon, L.</au><au>Hickey, P.</au><au>Manning, A.</au><au>Egan, K.</au><au>Breathnach, O.S.</au><au>O'Shea, C.</au><au>Christie, A.</au><au>Treanor, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CN43 Maintaining intravenous anti-cancer systemic therapy during COVID: Pharmacy and nursing factors</atitle><jtitle>Annals of oncology</jtitle><date>2021-09</date><risdate>2021</risdate><volume>32</volume><spage>S1272</spage><epage>S1272</epage><pages>S1272-S1272</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><pub>Elsevier Ltd</pub><doi>10.1016/j.annonc.2021.08.672</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2021-09, Vol.32, p.S1272-S1272 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8454362 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | CN43 Maintaining intravenous anti-cancer systemic therapy during COVID: Pharmacy and nursing factors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T11%3A22%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CN43%20Maintaining%20intravenous%20anti-cancer%20systemic%20therapy%20during%20COVID:%20Pharmacy%20and%20nursing%20factors&rft.jtitle=Annals%20of%20oncology&rft.au=O'Dwyer,%20R.T.&rft.date=2021-09&rft.volume=32&rft.spage=S1272&rft.epage=S1272&rft.pages=S1272-S1272&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1016/j.annonc.2021.08.672&rft_dat=%3Celsevier_pubme%3ES092375342102901X%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S092375342102901X&rfr_iscdi=true |